Purpose: The purpose of this pilot study is to determine preliminary estimates of the parameters related to the distribution of the study endpoints including: International Prostate Symptom Score (IPSS) and quality of life (QoL) score changes, Qmax changes, post void residual volume (PVR) changes, percent prostate infarction and presence of non-target embolization.